🔗 Share this article

The prestigious award in medical science was granted for revolutionary discoveries that illuminate how the immune system targets dangerous infections while protecting the body's own cells.

Three renowned researchers—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—share this accolade.

Their work uncovered unique "sentinels" within the immune system that eliminate malfunctioning immune cells capable of attacking the body.

The discoveries are now paving the way for new treatments for immune disorders and malignancies.

The winners will divide a monetary award worth 11 million SEK.

Crucial Findings

"Their work has been essential for understanding how the body's defenses functions and the reason we do not all suffer from severe autoimmune diseases," stated the head of the award panel.

The trio's studies explain a core mystery: How does the immune system protect us from numerous invaders while keeping our healthy cells unharmed?

The body's protection system uses immune cells that scan for signs of disease, including viruses and germs it has never encountered.

These defenders employ detectors—called recognition units—that are produced by chance in a vast number of variations.

That gives the defense network the ability to combat a broad range of invaders, but the unpredictability of the process inevitably produces immune cells that may target the host.

Security Guards of the Immune System

Scientists earlier knew that a portion of these harmful defense cells were eliminated in the thymus—where immune cells mature.

This year's Nobel Prize honors the identification of regulatory T-cells—described as the body's "security guards"—which patrol the body to disarm other immune cells that assault the body's own tissues.

It is known that this process fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "These findings have laid the foundation for a novel area of research and spurred the creation of innovative therapies, for instance for tumors and immune disorders."

Regarding cancer, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on reducing their quantity.

For self-attack disorders, experiments are exploring boosting T-reg cells so the body is not being harmed. A comparable approach could also be effective in minimizing the chances of organ transplant failure.

Pioneering Studies

Professor Sakaguchi, of Osaka University, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

The researcher demonstrated that introducing defense cells from healthy mice could prevent the illness—implying there was a system for blocking immune cells from attacking the body.

Dr. Brunkow, from the Institute for Systems Biology in a US city, and Fred Ramsdell, now at a biotech firm in a California city, were studying an genetic immune disorder in rodents and people that led to the identification of a gene vital for how regulatory T-cells operate.

"The groundbreaking research has revealed how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," said a leading physiology expert.

"This research is a striking example of how basic physiological study can have broad consequences for human health."